A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-weekly Dulaglutide With Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes and Moderate or Severe Chronic Kidney Disease
The purpose of this study is to determine the glycemic efficacy and safety of dulaglutide compared to insulin glargine in the treatment of participants with type 2 diabetes and moderate or severe chronic kidney disease.
Inclusion Criteria:
Exclusion Criteria:
Orangeburg, South Carolina 29118, United States
Sumter, South Carolina 29150, United States
Belém, 66073-000, Brazil
Curitiba, 80240-000, Brazil
Juiz de Fora, 36036-330, Brazil
Passo Fundo, 99010-080, Brazil
Porto Alegre, 90610000, Brazil
Santa Catarina, 89227680, Brazil
São Paulo, 04025-011, Brazil
Baja, 6500, Hungary
Budapest, 1036, Hungary
Esztergom, 2500, Hungary
Kaposvár, 7400, Hungary
Kecskemét, 6000, Hungary
Pécs, 7623, Hungary
Sátoraljaújhely, H-3980, Hungary
Siófok, 8600, Hungary
Chihuahua City, 31000, Mexico
Culiacán, 80030, Mexico
Guadalajara, 44650, Mexico
Mexico City, 11850, Mexico
Monterrey, 64000, Mexico
Gdansk, 80-952, Poland
Lodz, 90302, Poland
Szczecin, 70-111, Poland
Zgierz, 95-100, Poland
Bacau, 600114, Romania
Bucharest, 020045, Romania
Deva, 330084, Romania
Oradea, 410167, Romania
Târgu Mureş, 540142, Romania
Timișoara, 300125, Romania
Cape Town, 7925, South Africa
Durban, 4091, South Africa
Johannesburg, 2198, South Africa
Somerset West, 7130, South Africa
Worcester, 6850, South Africa
Barcelona, 08036, Spain
Valencia, 46026, Spain
Dnipropetrovsk, 49005, Ukraine
Kyiv, 2091, Ukraine
Luhansk, 91045, Ukraine
Poltava, 36011, Ukraine